Muscular Dystrophy – Modus Health

PUBLICATIONS

Modus Health’s StepWatch™ has been validated in over 500 peer-reviewed publications. Its superb accuracy has StepWatch™ being used as the gold standard by researchers and companies such as Google, Fitbit, and Samsung Digital Health for measuring the accuracy of their fitness monitors.

We’re also trusted by some of the most respected research institutions in the world.

You can browse our entire publications catalog below, or use this form to download a PDF copy of our publications listing.

K. J. Nolan, M. Yarossi, A. Ramanujam. Measuring ambulation in adults with central neurologic disorders. Phys Med Rehabil Clin N Am 2013; 24(2):247-63.

A. Govoni, F. Magri, S. Brajkovic, et al. Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy. Cell Mol Life Sci 2013; 70(23):4585-602.

S. Oftedal, K. L. Bell, L. E. Mitchell, P. S. Davies, R. S. Ware, R. N. Boyd. A systematic review of the clinimetric properties of habitual physical activity measures in young children with a motor disability. Int J Pediatr 2012; 2012:976425.

C. M. McDonald, E. K. Henricson, J. J. Han, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010; 41(4):500-10.

E. Mercuri, A. Mayhew, F. Muntoni, et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008; 18(11):894-903.

C. M. Wiles, M. E. Busse, C. M. Sampson, M. T. Rogers, J. Fenton-May, R. van Deursen. Falls and stumbles in myotonic dystrophy. J Neurol Neurosurg Psychiatry 2006; 77(3):393-6.

M. E. Busse, C. M. Wiles, R. W. van Deursen. Community walking activity in neurological disorders with leg weakness. J Neurol Neurosurg Psychiatry 2006; 77(3):359-62.

C. M. McDonald, L. M. Widman, D. D. Walsh, S. A. Walsh, R. T. Abresch. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2005; 86(4):802-8.

H. A. Hayes, D. Dibella, R. Crockett, M. Dixon, R. J. Butterfield, N. E. Johnson. Stepping Activity in Children With Congenital Myotonic Dystrophy. Pediatr Phys Ther 2018; 30(4):335-339.

M. E. Busse, O. R. Pearson, R. Van Deursen, C. M. Wiles. Quantified measurement of activity provides insight into motor function and recovery in neurological disease. J Neurol Neurosurg Psychiatry 2004; 75(6):884-8.